Medicenna Reports Confirmed Partial Response in Pancreatic Cancer and Clinical Update on MDNA11’s Monotherapy Dose Escalation Portion of the Ongoing Phase 1/2 ABILITY Study
Confirmed partial response in fourth-line metastatic pancreatic cancer patient, who had previously failed chemotherapy and…
Vocalbeats.AI Achieves ISO/IEC 42001 Certification, Reinforcing Responsible AI Governance